Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE It is unlikely that HER2 rs1136201 is a risk factor for breast cancer. 21474413

2011

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE One single-nucleotide polymorphism at codon 655 indicates a guanine-to-adenine substitution (Ile655Val) in the transmembrane domain-coding region of the HER-2/neu gene reported to be associated with increased risk of breast cancer. 21204706

2011

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE These study results suggest that Ile655Val polymorphism of the ERBB2 gene do not alter its activity and may not be associated with increased breast cancer risk among Chinese women. 17687647

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE The present study was conducted to clarify the diagnostic and prognostic significance of TNF-alpha and its combination with HER-2 Ile655Val SNP in breast cancer. 20872355

2011

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Animal studies and protein modeling suggest that the Ile655Val polymorphism located in the transmembrane domain of the HER2 protein might influence breast cancer development by altering the efficiency of homodimerization. 15987431

2005

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Furthermore, they provide clinical evidence that HER-2 Ile655Val SNP does affect serum HER-2 levels and it can be regarded as a predictive biomarker for breast cancer patients with poor prognosis. 18237248

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases. 18237245

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Ile655Val polymorphism of HER-2 gene was associated with a statistically significantly increased risk of breast cancer all above in homozygotes for Val allele. 16416013

2006

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE The present study was conducted to clarify the predictive and prognostic significance of serum TGF-I(2)1 in breast cancer in relation to Ile655Val single nucleotide polymorphism (SNP) of human epidermal growth factor receptor-2 (HER-2). 18348656

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Genomic DNA from 339 patients with breast cancer and 361 healthy control subjects was examined for the Val(655)Ile polymorphism with a polymerase chain reaction-restriction fragment-length polymorphism-based assay. 10699071

2000

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE We genotyped the Ile655Val single nucleotide polymorphism (rs1801200) in 1271 incident breast cancer cases, and 1667 controls who were selected from the Nurses' Health Study blood cohort. 15970791

2005

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE The P53 gene codon 72 Arg/Pro and Her2 gene Ile655Val polymorphisms were not associated with the risk of breast cancer in Turkish women. 20380571

2010

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE A single-nucleotide polymorphism (SNP) at codon 655, resulting in a G-to-A transition (Ile655Val) in the transmembrane domain-coding region of this gene has been associated with an increased risk of breast cancer, particularly among younger women. 12166652

2002

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE The HER2 I655V polymorphism and breast cancer risk in Ashkenazim. 14569185

2003

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Studies on the association between the Ile to Val polymorphism at codon 655 of the human epithelial growth factor receptor 2 (HER-2) gene and susceptibility to breast cancer have been reported for almost all ethnic populations, with both positive or negative conclusions. 18090908

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Two hundred and four cases and 138 controls were collected to investigate the association of HER-2 Ile655Val polymorphism with the risk of breast cancer development and progression in Iranian population. 15374636

2004

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE In summary, our meta-analysis findings suggest that the HER2 Ile655Val polymorphism is marginally associated with breast cancer susceptibility in worldwide populations with additive and dominant models, but not a recessive model. 25520082

2014

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Our study proposes the allelic imbalance of Ile655Val polymorphism between Greek Christian and Greek Muslim populations of Thrace contributes to the inconsistent association between this SNP and breast cancer risk across these two different ethnic groups. 17918664

2007

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE The association of HER-2/neu Ile655Val polymorphism and the risk of breast cancer was borderline significant with the heterozygous carrier being at higher risk. 18837888

2008

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE Although the biological role of the I655V polymorphism is not known, large independent studies of early onset breast cancer are warranted to attempt to replicate this finding. 14578152

2003

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE In conclusion, our meta-analysis suggests that HER2 Ile 655Val polymorphism may contribute to breast cancer risk. 20401632

2010

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE We have also evaluated a Val(655)Ile single nucleotide polymorphism, which is associated with an increased risk of breast cancer, in a subset of the colorectal cancer patients and in healthy control subjects. 11870539

2002

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE In this analysis, we measured the association between the Ile(655)Val variant and postmenopausal breast cancer among women participating in the Hawaii and Los Angeles Multiethnic Cohort. 11731415

2001

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE We studied the HER2 codon 655 (rs1136201) polymorphism in 80 Austrian patients with BC and 100 healthy volunteers by pyrosequencing and polymerase chain reaction. 26637882

2015

dbSNP: rs1136201
rs1136201
0.100 GeneticVariation BEFREE In this study we aimed to determine whether the risk of breast cancer is associated with the I655V polymorphism of HER2 transmembrane domain-coding region at codon 655. 18721072

2008